We are testing a new antibody-drug conjugate for patients with advanced non-small cell lung cancer. The study aims to see how effective it is and how individual responses may vary.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in the lungs. It is often diagnosed at a later stage and can be metastatic, meaning it has spread to other parts of the body.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.